Tang Capital Management LLC Corvus Pharmaceuticals, Inc. Transaction History

Tang Capital Management LLC

  • $1.17 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.87 - $2.03 $174,000 - $405,999
200,000 Added 6.45%
3,301,709 $3.27 Million
Q4 2021

Feb 14, 2022
SELL
$2.34 - $5.31 $1.52 Million - $3.44 Million
-647,670 Reduced 17.27%
3,101,709 $7.48 Million
Q3 2021

Nov 15, 2021
BUY
$1.89 - $8.53 $7.09 Million - $32 Million
3,749,379 New
3,749,379 $18.1 Million

Others Institutions Holding CRVS

# of Institutions
73
Shares Held
30.4M
Call Options Held
1.06M
Put Options Held
84.3K
View Full List

About Corvus Pharmaceuticals, Inc.

CRVS Quotes by TradingView
  • Ticker CRVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,553,500
  • Market Cap $223M
  • Description
  • Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...
More about CRVS
Track This Portfolio

Track Tang Capital Management LLC Portfolio

Follow Tang Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email